Description
Submental Fat Reduction
Indicated for improvement in the appearance of moderate-to-severe convexity or fullness associated with submental fat (ie, double chin) in adults
Injected into subcutaneous fat tissue in the submental area using an area-adjusted dose of 2 mg/cm²
A single treatment consists of up to a maximum of 50 injections, 0.2 mL each (up to a total of 10 mL), spaced 1 cm apart
Up to 6 single treatments may be administered at intervals no less than 1 month apart
Dosing Considerations
Safe and effective use for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended
Dose modifications
Geriatric: Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy
Adverse Effects
>10%
Edema/swelling at injection sites (87%)
Hematoma/bruising (72%)
Pain (70%)
Numbness (66%)
Erythema (27%)
Induration (23%)
Paresthesia (14%)
Nodule (13%)
Pruritus (12%)
1-10%
Headache (8%)
Skin tightness (5%)
Site warmth (4%)
Nerve injury (4%)
Oropharyngeal pain (3%)
Hypertension (3%)
Nausea (2%)
Dysphagia (2%)
Reviews
There are no reviews yet.